Prevention of experimental autoimmune uveoretinitis by blockade of osteopontin with small interfering RNA

• Iwata, Daiju

• Kitamura, Mizuki

• Kitaichi, Nobuyoshi

• Saito, Yoshinari

• Kon, Shigeyuki

• Namba, Kenichi

• Morimoto, Junko

• Ebihara, Akiko

• Kitamei, Hirokuni

• Yoshida, Kazuhiko

• Ishida, Susumu

• Ohno, Shigeaki

• Uede, Toshimitsu

• Onoé, Kazunori

• Iwabuchi, Kazuya

抄録

Osteopontin (OPN) is elevated during the progression of experimental autoimmune uveoretinitis (EAU) in C57BL/6 (B6) mice. Furthermore, EAU symptoms are ameliorated in OPN knockout mice or in B6 mice treated with anti-OPN antibody (M5). Recently, OPN has been shown to promote the Th1 response not only in the extracellular space as a secretory protein but also in cytosol as a signaling component. Thus, we attempted to reduce OPN in both compartments by using a small interfering RNA (siRNA) targeting the OPN coding sequence (OPN-siRNA). EAU was induced in B6 mice by immunization with human interphotoreceptor retinoid-binding protein (hIRBP) peptide sequence 1-20. The OPN- or control-siRNA was administered with hydrodynamic methods 24 hours before and simultaneously with immunization (prevention regimen). When plasma OPN levels were quantified following siRNA administration with the prevention regimen, the level in the OPN-siRNA-treated group was significantly lower than that in the control-siRNA-treated group. Accordingly, the clinical and histopathological scores of EAU were significantly reduced in B6 mice when siRNA caused OPN blockade. Furthermore, TNF-α, IFN-γ, IL-2, GM-CSF and IL-17 levels in the culture supernatants were markedly suppressed in the OPN-siRNA-treated group, whereas the proliferative responses of T lymphocytes from regional lymph nodes against immunogenic peptides was not significantly reduced. On the other hand, the protection was not significant if the mice received the OPN-siRNA treatment on day 7 and day 8 after immunization when the clinical symptoms appeared overt (reversal regimen). Our results suggest that OPN blockade with OPN-siRNA can be an alternative choice for the usage of anti-OPN antibody and controlling uveoretinitis in the preventive regimen.

収録刊行物

• Experimental Eye Research

  Experimental Eye Research 90 (1), 41-48, 2010-01

  Elsevier Ltd.

キーワード

• inflammation
• EAU
• OPN
• RNA interference
• uveitis

詳細情報

• CRID: 1050845763935844096
• NII論文ID: 120001821843
• HANDLE: 2115/42602
• ISSN: 00144835
• 本文言語コード: en
• 資料種別: journal article
• データソース種別:
  • IRDB
  • CiNii Articles